Literature DB >> 26287314

Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis.

Sean J Barbour1,2,3, Daniel C Cattran4,5, Gabriela Espino-Hernandez2, Michelle A Hladunewich4,5, Heather N Reich4,5.   

Abstract

The majority of our insight about glomerulonephritis (GN) is from observational research. Because proteinuria is an important element of outcome in GN, the validity of observational analyses is dependent on the metric used to model proteinuria. Previous metrics of proteinuria included the value at baseline, the average of all values over the entire follow-up (time-averaged), the instantaneous value at each time point (time-varying), or the average of all values prior to each time point, and each of these standardized to body surface area. It was not known which of these metrics best accounts for the risk of renal outcome and should be used in GN research. To address this, we studied 1351 adult patients with IgA nephropathy, focal segmental glomerulosclerosis, and membranous nephropathy from the Toronto GN Registry. Cox regression models for the risk of end-stage renal disease or a halving of estimated glomerular filtration rate included each proteinuria metric and were compared using model fit and discrimination. Proteinuria did not need to be standardized to body surface area. Time-varying proteinuria was the best metric to account for the prognostic effects of proteinuria over time, especially in focal segmental glomerulosclerosis and IgA nephropathy over the majority of follow-up, and in membranous nephropathy earlier in the disease course. Using alternate proteinuria metrics biased analyses up to 30.3%. These findings can improve the validity and design of future observational and prediction modeling studies in GN.

Entities:  

Year:  2015        PMID: 26287314     DOI: 10.1038/ki.2015.241

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

1.  Interpreting incremental value of markers added to risk prediction models.

Authors:  Michael J Pencina; Ralph B D'Agostino; Karol M Pencina; A Cecile J W Janssens; Philip Greenland
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

2.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

3.  Clinical features and outcomes of IgA nephropathy with nephrotic syndrome.

Authors:  Jwa-Kyung Kim; Jeong Ho Kim; Sang Choel Lee; Ea Wha Kang; Tae Ik Chang; Sung Jin Moon; Soo Young Yoon; Tae-Hyun Yoo; Shin-Wook Kang; Kyu Hun Choi; Dae Suk Han; Jeong Hae Kie; Beom Jin Lim; Hyeon Joo Jeong; Seung Hyeok Han
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

Review 4.  Risk stratification of patients with IgA nephropathy.

Authors:  Sean J Barbour; Heather N Reich
Journal:  Am J Kidney Dis       Date:  2012-04-11       Impact factor: 8.860

Review 5.  Obesity and kidney disease: potential mechanisms.

Authors:  Christopher Wickman; Holly Kramer
Journal:  Semin Nephrol       Date:  2013-01       Impact factor: 5.299

6.  Remission of proteinuria improves prognosis in IgA nephropathy.

Authors:  Heather N Reich; Stéphan Troyanov; James W Scholey; Daniel C Cattran
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

7.  A tricontinental view of IgA nephropathy.

Authors:  Colin C Geddes; Virpi Rauta; Carola Gronhagen-Riska; Lukasz P Bartosik; Alan G Jardine; Lloyd S Ibels; York Pei; Daniel C Cattran
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

8.  Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population--epidemiology and outcome.

Authors:  Jeroen K J Deegens; Eric J Steenbergen; George F Borm; Jack F M Wetzels
Journal:  Nephrol Dial Transplant       Date:  2007-08-17       Impact factor: 5.992

9.  IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.

Authors:  Rosanna Coppo; Licia Peruzzi; Alessandro Amore; Antonio Piccoli; Pierre Cochat; Rosario Stone; Martin Kirschstein; Tommy Linné
Journal:  J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 10.121

10.  Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.

Authors:  Jicheng Lv; Hong Zhang; Yang Zhou; Guangtao Li; Wanzhong Zou; Haiyan Wang
Journal:  Nephrology (Carlton)       Date:  2008-01-23       Impact factor: 2.506

View more
  17 in total

1.  Clinical study on Yishen Qufeng Shengshi Recipe () for glomerular proteinuria patients: A randomized controlled trial.

Authors:  Qin Dai; Pei-Qing Zhang; Xiao-Qin Wang; Li-Fang Nie; Xiao-Jun Fu; Wen Peng; Yi Wang; Jun Li; Yue-Ping Bi; Xiu-Hua Mi; Min Yuan; Li-Qun He
Journal:  Chin J Integr Med       Date:  2017-11-17       Impact factor: 1.978

2.  Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival.

Authors:  Safak Mirioglu; Yasar Caliskan; Yagmur Goksoy; Sibel Gulcicek; Yasemin Ozluk; Irem Sarihan; Nurhan Seyahi; Isin Kilicaslan; Aydin Turkmen; Mehmet Sukru Sever
Journal:  Int Urol Nephrol       Date:  2017-10-16       Impact factor: 2.370

Review 3.  Markers for the progression of IgA nephropathy.

Authors:  Dita Maixnerova; Colin Reily; Qi Bian; Michaela Neprasova; Jan Novak; Vladimir Tesar
Journal:  J Nephrol       Date:  2016-05-03       Impact factor: 3.902

4.  Proteinuria as a surrogate marker for renal outcome: are we there yet?

Authors:  Rupali S Avasare; Jai Radhakrishnan
Journal:  Kidney Int       Date:  2015-12       Impact factor: 10.612

5.  Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.

Authors:  Mark Canney; Sean J Barbour; Yuyan Zheng; Rosanna Coppo; Hong Zhang; Zhi-Hong Liu; Keiichi Matsuzaki; Yusuke Suzuki; Ritsuko Katafuchi; Heather N Reich; Daniel Cattran
Journal:  J Am Soc Nephrol       Date:  2020-12-23       Impact factor: 10.121

6.  Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

Authors:  Cristina Sarcina; Carmine Tinelli; Francesca Ferrario; Bianca Visciano; Antonello Pani; Annalisa De Silvestri; Ilaria De Simone; Lucia Del Vecchio; Veronica Terraneo; Silvia Furiani; Gaia Santagostino; Enzo Corghi; Claudio Pozzi
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

7.  The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis.

Authors:  Wen Xiu Chang; Ning Xu; Takanori Kumagai; Takeshi Shiraishi; Takahiro Kikuyama; Hiroki Omizo; Kazuhiro Sakai; Shigeyuki Arai; Yoshifuru Tamura; Tatsuru Ota; Shigeru Shibata; Yoshihide Fujigaki; Zhong Yang Shen; Shunya Uchida
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

8.  Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy.

Authors:  Xinxin Chen; Yu Chen; Keqing Shi; Yinqiu Lv; Huan Tong; Guangju Zhao; Chaosheng Chen; Bo Chen; Duo Li; Zhongqiu Lu
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

9.  Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.

Authors:  Jonathan P Troost; Howard Trachtman; Cathie Spino; Frederick J Kaskel; Aaron Friedman; Marva M Moxey-Mims; Richard N Fine; Jennifer J Gassman; Jeffrey B Kopp; Liron Walsh; Rong Wang; Debbie S Gipson
Journal:  Am J Kidney Dis       Date:  2020-08-10       Impact factor: 8.860

10.  Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs.

Authors:  Zhihao Huo; Huizhen Ye; Peiyi Ye; Guanqing Xiao; Zhe Zhang; Yaozhong Kong
Journal:  PeerJ       Date:  2021-07-06       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.